TrialHaematologica2012

The sorafenib plus nutlin-3 combination promotes synergistic cytotoxicity in acute myeloid leukemic cells irrespectively of FLT3 and p53 status.

Giorgio Zauli et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.